Evidence map›Paper›PMID 27565346›Full record

ArticleCell2016

Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation.

Daniel C Scott, David Y Rhee, David M Duda, Ian R Kelsall, Jennifer L Olszewski, Joao A Paulo, Annemieke de Jong, Huib Ovaa, Arno F Alpi, J Wade Harper and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 229 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. E2 variants for probing E3 ubiquitin ligase activities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Cul5bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. Biochemical analysis of PD-L1 ubiquitination by CRL3Structure (London, England : 1993) · 2025
    Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Daniel C ScottDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
David Y RheeDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
David M DudaDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Ian R KelsallMRC Protein Phosphorylation and Ubiquitylation Unit, Dundee DD1 5EH, UK.
Jennifer L OlszewskiDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Annemieke de JongDivision of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
Huib OvaaDivision of Cell Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Chemical Immunology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Arno F AlpiMRC Protein Phosphorylation and Ubiquitylation Unit, Dundee DD1 5EH, UK.
J Wade HarperDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: wade_harper@hms.harvard.edu.
Brenda A SchulmanDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: brenda.schulman@stjude.org.
St. Jude Children's Research Hospital · USHarvard University · USMRC Protein Phosphorylation and Ubiquitylation Unit · GBLeiden University Medical Center · NLThe Netherlands Cancer Institute · NL

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Ubiquitin Mediated Proteolysis and Cell Cycle ControlR01AG011085 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JEFFREY W HARPER · 1993 to 2026
$10.9M
Systematic discovery and functional analysis of the PARKIN modified proteomeR37NS083524 · NINDS · HARVARD MEDICAL SCHOOL · PI HARPER, JEFFREY W · 2013 to 2019
$3.0M
E3-mediated Ubiquitin-like Protein LigationR37GM069530 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SCHULMAN, BRENDA A · 2014 to 2018
$2.0M
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosisK01DK098285 · NIDDK · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2013 to 2017
$638k
European Research Council 281699Howard Hughes Medical InstituteNCI NIH HHS P30 CA021765NIA NIH HHS R01 AG011085NIDDK NIH HHS K01 DK098285NIGMS NIH HHS R37 GM069530NINDS NIH HHS R37 NS083524
6 · The paper itself

Abstract

Hundreds of human cullin-RING E3 ligases (CRLs) modify thousands of proteins with ubiquitin (UB) to achieve vast regulation. Current dogma posits that CRLs first catalyze UB transfer from an E2 to their client substrates and subsequent polyubiquitylation from various linkage-specific E2s. We report an alternative E3-E3 tagging cascade: many cellular NEDD8-modified CRLs associate with a mechanistically distinct thioester-forming RBR-type E3, ARIH1, and rely on ARIH1 to directly add the first UB and, in some cases, multiple additional individual monoubiquitin modifications onto CRL client substrates. Our data define ARIH1 as a component of the human CRL system, demonstrate that ARIH1 can efficiently and specifically mediate monoubiquitylation of several CRL substrates, and establish principles for how two distinctive E3s can reciprocally control each other for simultaneous and joint regulation of substrate ubiquitylation. These studies have broad implications for CRL-dependent proteostasis and mechanisms of E3-mediated UB ligation.

Indexed as

UbiquitinationCarrier ProteinsCullin ProteinsGene Knockdown TechniquesHEK293 CellsHumansMutationNEDD8 ProteinPolyubiquitinProteomicsSubstrate SpecificityUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesUbiquitinsARIH1 protein, humanCarrier ProteinsCUL3 protein, humanCullin ProteinsCULL-RING ligase, humanNEDD8 ProteinNEDD8 protein, humanPolyubiquitinRBX1 protein, humanSEC13 protein, humanUBE2L3 protein, humanUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesUbiquitins

Identifiers

PMID27565346
PMCPMC5091668
OpenAlexW2508968739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.